Kosuke Tanegashima

3PUBLICATIONS
14CO-AUTHORS
Molecular targetsEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 22, 2025
CXCL14 is an essential modulator of TLR9 agonist-induced antitumor immune responses.

Kosuke Tanegashima, Eiji Esashi, Koji Ishida

|Jun 15, 2022
Circadian protection against bacterial skin infection by epidermal CXCL14-mediated innate immunity.

Kojiro Tsujihana, Kosuke Tanegashima, Yasuko Santo

|Jul 15, 2021
Identification of Functional Domains of CXCL14 Involved in High-Affinity Binding and Intracellular Transport of CpG DNA.

Rina Iwase, Naoto Naruse, Miho Nakagawa

Pageof 1